SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
59 hedge funds and large institutions have $27.5M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $37.8M → $27.5M (-$10.3M)
Holders
59
Holding in Top 10
1
Calls
$700K
Puts
$1K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$248K | |
| 3 | +$234K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$132K |
| 5 |
LPL Financial
San Diego,
California
|
+$113K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.53M | |
| 3 | -$1.13M | |
| 4 |
E
Ergoteles
New York
|
-$65.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63K |